Video & Transcript Research : 'infectious diseases'
Page 33 of 230
MN
Minnesota 2025-2026 Regular Session
HF1501, bill to boost funding to rare disease advisory council, heard in health committee 3/5/25
Transcript Highlights:
- It was the same disease.
- It was the same disease.
- It was the same disease.
- It was the same disease.
- It was the same disease.
Summary:
The committee heard House File 1501, which would fund the Minnesota Rare Disease Advisory Council and make the current fiscal year 2025 budget its permanent base. Representative Murphy said the bill would provide about $342,000 in general fund money for the 2026-27 cycle and argued that the council helps shorten diagnosis times, support research, and keep Minnesota a leader in rare disease work. Erica Barnes, the council’s executive director, testified in support and explained that the council was established in 2022 to improve care for the estimated one in 10 Minnesotans living with a rare disease. She said the council needs the full $668,000 level it operated with this year to maintain its statutory duties, noting that the current ongoing base is about $326,000 and that the extra funding was previously one-time money.
Barnes described the barriers faced by rare disease patients, including long diagnostic delays, limited provider knowledge, and the fact that only a small share of rare diseases have FDA-approved treatments. She said rare disease care is costly to the health system and that the council has used prior funding to convene the community more regularly and carry out its work. Representative Leing questioned why the budget should be doubled and asked what additional work the council would do with the higher amount; Barnes responded that without the larger ongoing appropriation the council would fall back to 1.8 FTE and would have to stop some programs. Representative Hingson Jger spoke in support, saying the council’s collaboration has been valuable for policy work in the genetic and rare disease space.
In closing, Murphy emphasized Minnesota’s leadership in rare disease and shared a personal story about how diagnosis and treatment changed his family’s life. No public testimony was offered. The chair then laid House File 1501 over for possible inclusion in the omnibus bill.
TX
Transcript Highlights:
- But let's address the disease first.
- , Alzheimer's and dementia-related diseases.
- This is an expensive disease. It's a devastating disease.
- This is especially relevant in Texas, where these diseases include vascular disease, obesity, and smoking
- to the more common later-onset diseases.
Keywords:
dementia, research institute, Alzheimer's disease, Parkinson's disease, funding, grants, state health initiatives, research funding, state budget, prevention, healthcare, medical research, Dementia Prevention and Research Institute, disaster relief, flood preparedness, emergency funding, local government support, meteorological forecasting, district apportionment, legislative rules
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Higher Education Mar 19th, 2026
Joint Committee on Higher Education
Transcript Highlights:
- body and can lead to cancer and other diseases.
- This is not a lifestyle disease.
- When I was six, I was diagnosed with celiac disease.
- When I was six, I was diagnosed with celiac disease.
- I have celiac disease.
Summary:
The Joint Committee on Higher Education held a hearing on two late-filed bills, H. 5012 and S. 2927, titled An Act Relative to Student Access, Food, and Nutritional Information, also referred to by witnesses as the “Snack Act.” The bills would require schools to make gluten-free and allergen-related meal information easier to find online, including menus, ingredients, food safety procedures, and contact information, so students with celiac disease and other medically necessary dietary restrictions can safely participate in universal school meal programs. Committee leaders explained the hearing process and invited testimony from pre-registered and in-person witnesses.
Most testimony came from parents, students, physicians, and advocates who described celiac disease as a serious autoimmune condition requiring a strict lifelong gluten-free diet. Witnesses said many families avoid school meals because information is hard to find or not clearly communicated, and they emphasized that the bill would not create a new system so much as make existing information accessible. Several speakers cited research showing that many children with celiac disease do not participate in school breakfast and lunch programs, and that communication gaps between school administrators, nurses, and food service staff are a major barrier. Witnesses also said the bill could help students with food allergies more broadly and would support equity in the state’s universal school meals program.
A number of students with celiac disease gave personal testimony about feeling excluded, managing food anxiety, and relying on clear school communication to stay safe. One parent and clinician described a child’s severe malnutrition before diagnosis and shared a photo to illustrate the seriousness of gluten exposure, while other doctors discussed long-term health risks from uncontrolled celiac disease and the need for better access to safe meals. Committee members praised the witnesses, especially the young students, and asked questions about cross-contamination, school procedures, and whether regulations or agency action might also address the issue. Senator Joan Lovely, the Senate sponsor, briefly endorsed the bill and thanked the panel. No vote was taken during the hearing, and the committee closed the hearing after testimony concluded.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Higher Education Mar 19th, 2026
Joint Committee on Higher Education
Transcript Highlights:
- Like Sama will testify today, I myself have celiac disease.
- body and can lead to cancer and other diseases.
- This is not a lifestyle disease.
- When I was six, I was diagnosed with celiac disease.
- I have celiac disease.
Keywords:
student nutrition, food allergies, celiac disease, gluten-free meals, allergen-free meals, medically restricted diets, school meals, college dining, K-12 education, higher education, disability access, accessibility services, food service, nutrition information, website disclosure, school website, meal accommodations, special diets, Massachusetts General Laws, Chapter 71
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Higher Education Jun 21st, 2026 at 12:00 pm
Joint Committee on Higher Education
Transcript Highlights:
- Like Sama will testify today, I myself have celiac disease.
- body and can lead to cancer and other diseases.
- This is not a lifestyle disease.
- When I was six, I was diagnosed with celiac disease.
- I have celiac disease.
Summary:
The Joint Committee on Higher Education held a hearing on two late-filed bills, S. 2927 and H. 5012, titled An Act Relative to Students Accessing Food and Nutritional Information, filed by Senator Joan Lovely and Representative Michelle Badger. The bills would require schools to make clear, centralized online information available about gluten-free and allergen-free meals, including menus, food safety procedures, and contact information, so students with celiac disease and other medically necessary dietary restrictions can safely participate in universal school meal programs. Committee members and the bill sponsors emphasized that the measure is intended to improve transparency, equity, and access within the Commonwealth’s universal free breakfast and lunch program.
Testimony came from students, parents, physicians, and advocates, many of whom described celiac disease as a serious autoimmune condition requiring a strict lifelong gluten-free diet. Witnesses said families often struggle to find reliable school meal information, and that lack of communication between school administrators, nurses, and food service staff can lead families to opt out of school meals even when safe options exist. Medical witnesses from Boston Children’s, Mass General, and Beth Israel said the bill addresses a real barrier identified in research and could help prevent health problems, missed school, and long-term complications from gluten exposure. Several witnesses also noted that the bill’s approach could benefit students with food allergies more broadly.
Committee members praised the testimony, especially from young student witnesses, and discussed practical issues such as cross-contamination, 504 plans, and whether schools already have the underlying information needed to comply. One member suggested the Department of Public Health might be able to address some of the issue through regulations, similar to a prior restaurant allergy-protocol change. No vote was taken during the hearing, and the committee closed after hearing from all panels and the bill sponsors, who asked for favorable consideration.
FL
Florida 2025 Regular Session
November 5, 2025 - 10:30 AM
Transcript Highlights:
- So, while the individual diseases may be rare, the total number of people impacted by rare disease is
- Council, provide us a briefing on the Florida Rare Disease Council, Pediatric Rare Disease Grant Program
- Individuals have a rare disease.
- Of rare diseases in the state.
- Sustainable funding for rare disease research.
Summary:
The Health Professions and Program Subcommittee met with a quorum present and received a briefing from Melissa Jordan, Assistant Deputy Secretary for Health and chair of the Florida Rare Disease Advisory Council (ARDAC). Jordan explained that rare diseases affect fewer than 200,000 people each individually, but together impact an estimated 2.3 million Floridians. She reviewed ARDAC’s structure, its three subcommittees, and its 2025 legislative report recommendations, which focused on expanding Florida-specific data, disaster preparedness, state agency coordination, insurance oversight, provider education, faster diagnostic tools, research collaboration, and establishing centers of excellence. She also highlighted ARDAC’s work with other states and its effort to build an online repository of resources for families and providers.
Jordan discussed the Andrew John Anderson Pediatric Rare Disease Grant Program, funded at $500,000 annually, which supported research awards at Florida State University and the University of Miami in 2024 and another University of Miami project in 2025. She also described House Bill 907 and the Sunshine Genetics Act pilot program, which created the Florida Institute for Pediatric Rare Diseases at FSU and a newborn whole-genome sequencing pilot to screen volunteer infants for hundreds of conditions beyond traditional newborn screening. The institute will include research, training, clinical care, a diagnostic lab, genome editing capacity, and a sequencing pilot overseen by a board, consortium, and steering committee.
Members asked about interstate collaboration, the scope of data collection beyond Medicaid, how the council reduces family financial burdens, how families and providers can learn about available resources, and how ARDAC measures effectiveness. Jordan said Florida has learned from other states’ survey-based approaches and instead is using administrative data sources such as Medicaid, hospitalizations, emergency department visits, birth and death certificates, with more clinical data to be added over time. She said success is tracked through annual reports, ongoing work plans, and quarterly research reports that measure progress, patient enrollment, treatment outcomes, and potential follow-on funding. The meeting concluded after the presentation and questions, and the subcommittee adjourned without further business.
CA
California 2025-2026 Regular Session
Assembly Floor Session Feb 23rd, 2026
California House Floor Meeting
Transcript Highlights:
- As the Vice Chair of the Rare Disease Caucus, I am proud to rise today to introduce ACR 132, Rare Disease
- diseases.
- someone with a rare disease.
- Rare Disease Day is observed on the last day of February to raise awareness about rare diseases and their
- Rare disease day is observed on the last day of February to raise awareness about rare diseases and their
Summary:
The Assembly met with a quorum call at the start, then proceeded with Black History Month observances, including a libation ceremony, the Pledge of Allegiance, and remarks emphasizing remembrance, ancestry, and the importance of honoring Black history. The chamber also handled routine procedural matters, including dispensing with the journal, re-referring certain Senate budget items to the Budget Committee, and allowing guest introductions and other unanimous-consent requests.
The main floor action was on Assembly Concurrent Resolution 134, recognizing Black History Month. Members from multiple caucuses spoke in support, highlighting the historical contributions of Black Americans, the ongoing effects of slavery and segregation, the need to protect voting rights and education, and the importance of solidarity across communities. The resolution was adopted by voice vote after 74 co-authors were added.
The Assembly also adopted Assembly Concurrent Resolution 132, declaring February 28 as Rare Disease Day. Members shared personal stories about ALS and other rare diseases, described barriers to diagnosis, treatment, and insurance coverage, and called for more research and support. The resolution received broad bipartisan support, with 71 co-authors added before adoption by voice vote.
The chamber then recognized a series of Black History Month Unsung Heroes honorees, including community leaders, health professionals, advocates, and public servants, and later heard additional guest introductions. The meeting concluded with adjournments in memory of Peyton Trilling and John Jackson, followed by announcements and adjournment until February 26 at 9 a.m.
CA
California 2025-2026 Regular Session
Assembly Floor Session Feb 23rd, 2026
California House Floor Meeting
Transcript Highlights:
- As the Vice Chair of the Rare Disease Caucus, I am proud to rise today to introduce ACR 132, Rare Disease
- diseases.
- someone with a rare disease.
- Rare Disease Day is observed on the last day of February to raise awareness about rare diseases and their
- , to becoming a rare disease family member.
TX
Transcript Highlights:
- Parkinson's disease. Correct.
- It's a terrible disease. All of these diseases are terrible.
- Oh yes, that's a huge issue in all diseases, but especially for dementia disease.
- So unlike Alzheimer's, this is a monogenetic disease. We know what causes this. disease.
- It's not just a motor disease. It affects every part of us. Again, it's a brain disease.
CA
California 2025-2026 Regular Session
Assembly Floor Session Feb 24th, 2025
California House Floor Meeting
CO
Colorado 2026 Regular Session
Colorado Senate 2026 Legislative Day 086 Apr 10th, 2026
Colorado Senate Floor Meeting
Transcript Highlights:
- </c> rare diseases. rare diseases.
- ,</c> One of those diseases, one of those diseases, you're going to believe that.
- </c> rare disease drugs." rare disease drugs."
- </c> coverage for rare disease patient. coverage for rare disease patient.
- </c> Colorado Rare Disease Advisory Council." Colorado Rare Disease Advisory Council."
Summary:
The Senate met with a quorum, approved the journal, and then proceeded out of order to consider Senate Joint Resolution 20, recognizing April 9, 2026, as Home Education Day in Colorado. Senator Pelton spoke in strong support of home education, describing it as a parent-led choice that benefits students and families. The resolution was adopted on a 30-0 vote, and the current roll was added as co-sponsors.
The chamber then took up the consent calendar and passed House Bill 1229, House Bill 1244, and Senate Bill 153. HB 1229, which concerns the human-animal bond as a social determinant of health, drew three no votes from Senators Pelton, Zamora Wilson, and Baeza; the other two measures passed unanimously. The Senate also laid over third reading of bills until Friday, April 10.
In Committee of the Whole, senators considered Senate Bill 72, which increases criminal penalties for assaultive conduct involving a motor vehicle and adds causing death with a motor vehicle to criminally negligent homicide. The committee adopted the report and advanced the bill on second reading. Later, the chamber laid over Senate Bill 134 and House Bill 1084 until April 10, and then took up Senate Bill 140, which would exempt certain rare disease and plasma therapies from review by the Prescription Drug Affordability Review Board. Sponsors and supporters argued the bill protects access for patients with rare diseases and prevents harm to treatment development, while opponents said it would weaken the PDAB’s affordability work and was too broad. Senators Weisman and Gonzales spoke against the bill, with Weisman citing concerns about the federal definition used and Gonzales defending the PDAB’s role in lowering drug costs; the debate continued in the transcript without a final vote shown.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Financial Services Jun 21st, 2026 at 10:30 am
Joint Committee on Financial Services
Transcript Highlights:
- So there's a medical permanent health disease.
- Sickle cell disease is a disease of Black and brown people, and our health care system is intrinsically
- Sickle cell disease, however, has languished as our patients Sickle cell disease, however, has languished
- This disease makes it very, very difficult.
- And having a disease like alopecia is so...
Summary:
The hearing opened with the Senate and House chairs of the Joint Committee on Financial Services explaining that the day’s agenda would focus on health insurance and other insurance matters, with a large number of witnesses and a request for brief testimony. Legislators were taken out of order to accommodate their schedules, and the committee heard testimony on several bills, including coverage for hair prostheses for alopecia (H. 1223/S. 832), medically necessary oral and dental care for head and neck cancer survivors (H. 1258), modernizing fertility and family-building coverage (H. 715/H. 1190 and related bills), coverage for prosthetic devices to support physical activity for people with limb loss (the “So Everybody Can Move” bill), remediation coverage for home heating oil releases (S. 813/H. 1302), and expanded access to physical therapy for Ehlers-Danlos syndrome (H. 1170). A separate bill on sickle cell care and registry development (S. 788) was also discussed by Senator Liz Miranda.
Witnesses largely offered personal stories and expert testimony in support of the bills. Advocates for alopecia coverage described the medical and emotional impact of hair loss, the high cost of quality wigs, and the argument that scalp and facial hair prostheses should be treated like other medically necessary prosthetics. Cancer survivors and supporters of H. 1258 said oral and dental care after head and neck cancer treatment is a quality-of-life issue and often not covered despite major out-of-pocket costs. Fertility specialists, LGBTQ+ advocates, and legislators supporting the modern family-building bills said the current infertility definition is outdated and discriminatory, excluding same-sex couples, people needing donors or gestational carriers, and others with medical barriers to conception. For the limb-loss bill, parents and adults with prosthetic needs stressed that activity-specific prostheses are essential for children and adults to run, swim, play sports, and stay healthy, but are often excluded from coverage.
The home heating oil testimony focused on the financial devastation caused by residential oil spills and the need to make spill coverage automatic in homeowners policies. Environmental professionals and homeowners described cleanup costs ranging from tens of thousands to hundreds of thousands of dollars, the strict liability homeowners face, and the fact that many policyholders do not know the rider exists. The insurance industry testified in opposition to the mandatory-coverage approach, arguing for clearer distinctions between first- and third-party coverage, risk-mitigation standards, a delayed effective date, and more emphasis on education and notification rather than mandates. Committee members pressed the industry witness on why agents do not routinely tell customers about the rider and suggested that the issue may require broader disclosure by insurers, agents, and fuel dealers. No votes were taken during the hearing; the committee heard testimony and discussed possible compromise language and future action.
AL
Alabama 2025 Regular Session
Alabama House Agriculture and Forestry Committee Apr 9th, 2025
Agriculture and Forestry
Transcript Highlights:
- It is the cheap version of wasting disease—basically the same disease.
- we spread the disease and all sorts of things.
- Deer breeders will be the cure for the disease.
- or other diseases.
- animals like... or disease with other animals like cows.
Bills:
HB509
Keywords:
HB509, game breeder, game breeder license, cervid, deer breeder, whitetail deer, elk, fallow deer, deer farm, captive deer, cervidae, wildlife disease, disease testing, antemortem testing, state veterinarian, Department of Conservation and Natural Resources, property rights, private property, animal transfer, breeding stock
AR
Arkansas 2026 1st Special Session
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL Jul 9th, 2026
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL
Transcript Highlights:
- We to detect this disease earlier and less expensive.
- It's a very exciting time to work on this disease.
- disease.
- Because as the disease progresses, the needs of the families change.
- Because as the disease progresses, the needs of the families change.
Summary:
The Arkansas Alzheimer’s Disease and Dementia Advisory Council met to introduce members, adopt its rules and procedures, approve prior minutes, and authorize the co-chairs to approve special expenses. The main discussion focused on updating the Arkansas State Plan for Alzheimer’s disease and dementia, with David Cook of the Alzheimer’s Association outlining major changes in prevalence, caregiving burden, diagnostics, and treatment since the prior plan. He noted rising disease and caregiver numbers in Arkansas, the expansion of amyloid PET access, the growing use of blood-based biomarkers, and the availability of FDA-approved treatments such as Leqembi and Kisunla, while emphasizing that access, insurance coverage, and provider education remain major barriers.
Members and presenters also discussed the need to better reach rural primary care providers, who may not be aware of new diagnostics and therapies, and the bottlenecks caused by limited specialists and infusion capacity. There was concern about overreliance on blood tests without confirmatory evaluation, and several members stressed the importance of collaboration, public education, and promoting brain health through exercise and diet. The council also heard about existing programs such as the dementia services coordinator, the BOLD grant, caregiver respite grants, workforce training, and a pilot dementia resource center with UAMS Centers on Aging.
The council approved a new four-part outline for the next state plan: advancing risk reduction and brain health/early detection, strengthening family caregiver support, improving access to diagnostics and treatment, and supporting access and quality of care, including workforce and crisis response. Members also agreed to consider future agenda items on new treatments, brain health and lifestyle prevention, workforce training, and possible legislative changes to the enabling statute. The meeting ended with discussion of scheduling the next meeting, tentatively set for August 12 in Hot Springs, and adjournment.
MO
Missouri 2026 Regular Session
Special Committee on Tourism Feb 4th, 2026 at 12:00 pm
Special Committee on Tourism
Transcript Highlights:
- And I said, listen, you know, it's not just about her story and her disease.
- And if they would... ...in some way through a rare disease.
- Disease, cancer knows no party. We're all one family.
- Disease, cancer knows no party. We're all one family.
- The NIH says that rare diseases occur at a rate of 1 in 200,000, but we don't test children for diseases
Summary:
The Special Committee on Tourism met with 10 members present, entered executive session, and approved House Bill 1651 by a vote of 11-0. The committee then moved to public hearings.
House Bill 1756, sponsored by Representative Steinmeyer, would designate the first full week in September as June’s Week and Rare Pediatric Disease Week in Missouri. Steinmeyer described the bill as a response to his granddaughter June’s rare pediatric brain cancer diagnosis and treatment, and said the goal is to raise awareness of rare pediatric diseases, connect families with resources, and encourage media coverage and public education. Several witnesses testified in support, including family members and advocates who spoke about the emotional and practical challenges of rare disease, the need for research and awareness, and the value of honoring affected children and families. No opposition was presented.
House Bill 1828, sponsored by Representative Violet, would authorize state support for maintenance and operations at the Missouri National Veterans Memorial in Perryville, subject to appropriation and available funds. Violet said the memorial provides reflection, healing, and education for veterans and families, and that the bill follows prior legislative support for the site without taking funds from other veterans’ projects. A memorial representative testified that the measure would establish a precedent similar to other veterans memorial funding and help preserve the facility. The committee heard no opposition, and the hearing on HB 1828 concluded with no further business before adjournment.
MN
Minnesota 2025-2026 Regular Session
MA cover weight-loss drugs 3/25/26
Minnesota House Floor Meeting
Transcript Highlights:
- diseases to manage, cancer, sleep apnea, osteoarthritis, kidney disease, liver disease, lower quality
- We are able to target other diseases and expensive diseases to manage, cancer, expensive diseases to
- > quality</c><00:10:34.560><c> of</c> disease, liver disease, lower quality of disease, liver disease
- We heard health outcomes, reductions in heart disease, liver disease.
- We heard health outcomes, reductions in heart disease, liver disease.
MN
Minnesota 2025-2026 Regular Session
House/Senate Press Conference 3/11/26
Transcript Highlights:
- One of them is um neurological disease.
- </c> their careers because of this disease. their careers because of this disease.
- </c><00:07:38.319><c> This</c> time as the disease progress. This time as the disease progress.
- </c> the disease an extra bite. the disease an extra bite.
- Parkinson's is the world's fastest-growing neurological disease.
Summary:
The meeting focused on two Parkinson’s-related bills in Minnesota: one to ban paraquat and another to create a state Parkinson’s research trust fund. Rep. Christy Purcell said the research bill would create a dedicated pot of money to coordinate and fund Parkinson’s research in Minnesota, with Sen. Mann as the Senate author. Supporters said Minnesota should act because Parkinson’s is growing rapidly, there is no cure, and state institutions could serve as a research hub.
Several people living with Parkinson’s testified about the personal and family impact of the disease, including early-onset diagnoses, loss of work, mobility challenges, and the burden on caregivers. Speakers from the Parkinson’s Foundation and the Michael J. Fox Foundation supported both bills, arguing that paraquat is strongly linked to Parkinson’s, that exposure can affect farmers and nearby residents, and that prevention and research are both needed. The paraquat bill was described as especially important because alternatives exist and the chemical is reportedly used very little in Minnesota.
During the discussion, Rep. Hansen said the paraquat bill would be held over and not voted on that day because a fiscal note was requested. He said the committee would hear the bill later that day and urged colleagues to keep an open mind. In response to questions, supporters said they anticipated little opposition beyond chemical-industry interests, and they emphasized that the bill was aimed specifically at paraquat rather than other chemicals. The research bill was discussed as a possible $25 million request, though no vote was taken on that proposal in the transcript.
FL
Florida 2026 Regular Session
Appropriations Committee on Health and Human Services Feb 12th, 2026
Appropriations Committee on Health and Human Services
Transcript Highlights:
- But I have also had doctors and nurses come ask me, how long have I had sickle cell disease?
- I was born with sickle cell disease. My pain crisis happened at just three months old.
- My name is Ken Lee LaFrance, and I live with sickle cell disease.
- It is a full-body organ-damaging disease. It is a full-body organ-damaging disease.
- This disease affects quality of life. Because of sickle cell, I've had my gallbladder removed.
MO
Missouri 2026 Regular Session
Special Committee on Tourism Feb 4th, 2026
Special Committee on Tourism
Transcript Highlights:
- And I said, listen, you know, it's not just about her story and her disease.
- Disease, cancer knows no party. We're all one family.
- Disease, cancer knows no party. We're all one family.
- The NIH says that rare diseases occur at a rate of 1 in 200,000, but we don't test children for diseases
- I have celiac disease. I wasn't diagnosed with that until about 10 years ago.
Summary:
The Special Committee on Tourism first met in executive session and approved House Bill 1651 by a vote of 11-0. The committee then held a public hearing on House Bill 1756, which would designate the first full week in September as “June’s Week” and Rare Pediatric Disease Week in Missouri. Sponsor Representative Steinmeyer described his granddaughter June’s battle with a rare pediatric brain tumor and said the bill is intended to raise awareness of rare pediatric diseases, connect families with support, and encourage media coverage and education. Several witnesses testified in support, including family members and advocates who spoke about the emotional, financial, and diagnostic challenges faced by families dealing with rare childhood illnesses; there was no opposition testimony.
Committee members expressed sympathy and support, with several noting the importance of awareness and the lack of pediatric cancer research. Questions focused on why September was chosen and what activities might occur during the week; the sponsor said he wanted the designation to avoid conflict with June’s birthday and to create space for media stories and educational outreach. Supporters emphasized that the bill would not require funding, only recognition, and that it could help families feel less isolated.
The committee also heard House Bill 1828, sponsored by Representative Violet, which would authorize state support for maintenance and operations at the Missouri National Veterans Memorial in Perryville when needed and subject to appropriation. The sponsor said the memorial serves veterans and families through reflection, healing, and education, and that the bill follows precedent from other memorial funding arrangements without diverting money from other Veterans Commission priorities. A memorial representative testified that the site has already received significant state-supported construction funding and that the bill would help preserve and maintain the facility. There was no opposition, and the hearing concluded with no further business and adjournment.
MO
Missouri 2026 Regular Session
Higher Education and Workforce Development Jan 20th, 2026 at 12:00 pm
Higher Education and Workforce Development
Transcript Highlights:
- As we know, these types of diseases, it doesn't affect one party. Absolutely right.
- And I think what we've had to learn through genetic disease and pediatric disease, and you heard Dr.
- The truth is that rare disease in the aggregate is quite common.
- These are genetic and pediatric diseases.
- But again, we do that with a bit of an at-war lens, you know, with this disease.
Summary:
The Committee on Higher Education and Workforce Development convened and heard testimony on House Bill 2740, a proposal to create a University of Missouri-based governance structure focused on rare pediatric disease research, especially pediatric cancer and neurogenetic conditions. The bill sponsor described it as a family-centered, time-limited effort to improve coordination, transparency, and accountability around existing research assets, with an annual public report to the General Assembly and a sunset date in 2030. Members repeatedly raised questions about who would appoint the patient/family and nonprofit representatives, whether legislators should serve on the board, how conflicts involving industry would be handled, and whether the board had enough defined authority and structure. Several members suggested the bill may need cleanup to clarify its purpose, appointments, meeting schedule, and whether it is truly a governing board or more of a task force/reporting body.
University of Missouri Executive Vice Chancellor for Health Affairs Rick Barron testified in strong support, saying the university is already collaborating across campuses and entities like MURR, NextGen Precision Health, and the School of Medicine on rare pediatric cancer and neurogenetic research. He said the bill would mainly formalize reporting and communication to the legislature, help showcase ongoing work, and support future funding and strategic growth; he also said he would not favor an industry representative on the board. John Ruth, a parent advocate involved in rare disease research, also supported the concept, emphasizing that these diseases affect families across party lines and that the goal should be to move from research papers to results that improve lives. Additional supporters, including a parent whose daughter survived childhood leukemia, said the bill could help families navigate the shock and complexity of rare disease diagnoses. No opposition testimony was presented, and the hearing on House Bill 2740 was concluded and adjourned.